中国临床保健杂志
中國臨床保健雜誌
중국림상보건잡지
CHINESE JOURNAL OF CLINICAL HEALTHCARE
2013年
6期
582-584
,共3页
冬兰%尹秋生%施冰%张健
鼕蘭%尹鞦生%施冰%張健
동란%윤추생%시빙%장건
抗药性,细菌%铜绿假单胞菌%鲍氏不动杆菌
抗藥性,細菌%銅綠假單胞菌%鮑氏不動桿菌
항약성,세균%동록가단포균%포씨불동간균
Drug resistance,bacterial%Pseudomonas aeruginosa%Acinetobacter baumannii
目的:分析多重耐药鲍曼不动杆菌与多重耐药铜绿假单胞菌的耐药性,为临床治疗提供依据。方法用 VITEK-32微生物自动鉴定与药敏系统,对临床分离出的非重复铜绿假单胞菌56株、鲍曼不动杆菌72株进行鉴定、药敏试验,并对比分析两种菌的耐药性。结果鲍曼不动杆菌对阿米卡星、左氧氟沙星的耐药率最低,分别为2.8%和68.1%。铜绿假单胞菌对哌拉西林/他唑巴坦的耐药率最低,为19.6%,其次为阿米卡星与亚胺培南,均为37.5%。鲍曼不动杆菌对哌拉西林/他唑巴坦、庆大霉素、妥布霉素、氨曲南、环丙沙星、左氧氟沙星、头孢吡肟、头孢他啶和亚胺培南的耐药率明显高于铜绿假单胞菌,差异有统计学意义(P <0.01或 P <0.05),只有对阿米卡星的耐药率低于铜绿假单胞菌(P <0.01)。71.7%的鲍曼不动杆菌只对阿米卡星敏感,鲍曼不动杆菌的多重耐药率(97.2%)显著高于铜绿假单胞菌(67.9%),P <0.01。结论铜绿假单胞菌、鲍曼不动杆菌的多重耐药现象严重,尤其是鲍曼不动杆菌,应加强耐药性监测。
目的:分析多重耐藥鮑曼不動桿菌與多重耐藥銅綠假單胞菌的耐藥性,為臨床治療提供依據。方法用 VITEK-32微生物自動鑒定與藥敏繫統,對臨床分離齣的非重複銅綠假單胞菌56株、鮑曼不動桿菌72株進行鑒定、藥敏試驗,併對比分析兩種菌的耐藥性。結果鮑曼不動桿菌對阿米卡星、左氧氟沙星的耐藥率最低,分彆為2.8%和68.1%。銅綠假單胞菌對哌拉西林/他唑巴坦的耐藥率最低,為19.6%,其次為阿米卡星與亞胺培南,均為37.5%。鮑曼不動桿菌對哌拉西林/他唑巴坦、慶大黴素、妥佈黴素、氨麯南、環丙沙星、左氧氟沙星、頭孢吡肟、頭孢他啶和亞胺培南的耐藥率明顯高于銅綠假單胞菌,差異有統計學意義(P <0.01或 P <0.05),隻有對阿米卡星的耐藥率低于銅綠假單胞菌(P <0.01)。71.7%的鮑曼不動桿菌隻對阿米卡星敏感,鮑曼不動桿菌的多重耐藥率(97.2%)顯著高于銅綠假單胞菌(67.9%),P <0.01。結論銅綠假單胞菌、鮑曼不動桿菌的多重耐藥現象嚴重,尤其是鮑曼不動桿菌,應加彊耐藥性鑑測。
목적:분석다중내약포만불동간균여다중내약동록가단포균적내약성,위림상치료제공의거。방법용 VITEK-32미생물자동감정여약민계통,대림상분리출적비중복동록가단포균56주、포만불동간균72주진행감정、약민시험,병대비분석량충균적내약성。결과포만불동간균대아미잡성、좌양불사성적내약솔최저,분별위2.8%화68.1%。동록가단포균대고랍서림/타서파탄적내약솔최저,위19.6%,기차위아미잡성여아알배남,균위37.5%。포만불동간균대고랍서림/타서파탄、경대매소、타포매소、안곡남、배병사성、좌양불사성、두포필우、두포타정화아알배남적내약솔명현고우동록가단포균,차이유통계학의의(P <0.01혹 P <0.05),지유대아미잡성적내약솔저우동록가단포균(P <0.01)。71.7%적포만불동간균지대아미잡성민감,포만불동간균적다중내약솔(97.2%)현저고우동록가단포균(67.9%),P <0.01。결론동록가단포균、포만불동간균적다중내약현상엄중,우기시포만불동간균,응가강내약성감측。
Objective To analysis multidrug-resistant of Pseudomonas aeruginosa and Acinetobacter bau-mannii isolated from hospitalized patients and provide reliable reference for rational clinical use of antibiotics.Meth-ods The identification and antibiotics resistance test of 56 strains of Pseudomonas aeruginosa and 72 stranis of Acin-etobacter baumannii isolated from patients in emergency department from May 2009 to Oct 2011 were performed by VITEK-32 system.Results The resistance rate of Acinetobacter baumannii to Amikacin was the lowest (2.8%),fol-lowed by Levofloxacin(68.1%).The antibiotics resistance rate of Pseudomonas aeruginosa to Piperacillin/tazobactam was lowest(19.6%),followed by Amikacin and Imipenem(37.5%).The antibiotics resistance rate of Acinetobacter baumannii to Piperacillin/tazobactam,Gentamycin,Tobramycins,Aztreonam,Levofloxacin,Ciprofloxacin,Ceftazidime, Cefepime and Imipenem were significantly higher than that of Pseudomonas aeruginosa (P <0.01 or P <0.05),ex-cept for Amikacin,the resistance rate of Acinetobacter baumannii was lower than that of Pseudomonas aeruginosa (P<0.01).The multidrug-resistant rate of Acinetobacter baumannii (97.2%)was significantly higher than that of Pseudomonas aeruginosa(67.9%)(P <0.01),with 71.7% of Acinetobacter baumannii was only sensitive to Ami-kacin.Conclusion The multidrug-resistant rates of Pseudomonas aeruginosa and Acinetobacter baumannii are high, especialy for Acinetobacter baumannii.The antibiotics resistance monitoring and rational use should be paid more at-tention according to the results of drug susceptibility test.